CONTENTS

 Issue 83 | June 2019

In association with

goodbye mr gottlieb

Looking back at Scott Gottlieb's two year tenure at the helm of the FDA 

Pharmaoffer

A digital platform is helping drugmakers to connect with qualified material suppliers

The future of parkinson's

Could GDNF still form the basis for an effective Parkinson’s therapy?

CBD: myth vs medicine

Seperating the fact from fiction surrounding pharmaceutical CBD

pregnancy proteins

A pregnancy protein could form the foundation for new drugs

underground resistance

Sewage samples suggest that bad sanitation is driving antimicrobial resistance

02/23/2024 21:35:18
  • Home | Ingredients on demand
  • In this issue
  • Scandinavian Health
  • Contents
  • Daiichi Jitsugyo
  • News
  • Hapa Company Insight
  • Gerteis Company Insight
  • Gerteis
  • The pharma industry briefing
  • Accurate Biometrics Company Insight
  • Accurate Biometrics
  • Scott Gottlieb: achievements of the outgoing FDA commissioner
  • Capsugel
  • Alpex
  • Can Pharmaoffer become the Amazon of pharma raw materials?
  • Molnar Company Insight
  • Molnar
  • Is growth factor protein the future of Parkinson’s treatment?
  • AEB Company Insight
  • AEB
  • CBD: the myth, the magic and the real deal drugs
  • Swiss WorldCargo
  • Moehs Iberica SL
  • Could a pregnancy protein hold promise for new drugs?
  • AtoZ-CRO GmbH Company Insight
  • AtoZ-CRO GmbH
  • Antimicrobial resistance: sewage samples reveal bad sanitation as a key driver
  • BEA
  • 3M
  • Pfanstiehl
  • Events
  • Richter Helm
  • Event: CPhl Korea
  • TSS Company Insight
  • TSS AB
  • Next issue
  • Baxter
05/23/2019 00:00:00